Consistent with these results, a reduction in the positive charge

Consistent with these results, a reduction in the positive charge for control PEI/TPGS-b-(learn more PCL-ran-PGA) nanoparticles (ENP) was obtained because the TPGS-b-(PCL-ran-PGA) nanoparticles (DNP) was induced by the addition of negatively charged pDNA. The ability of all TPGS-b-(PCL-ran-PGA)/PEI nanoparticles to immobilize pDNA was confirmed by agrose gel electrophoresis (Figure 4C). In a recent report, the pDNA complexed to the polymeric (poly(lactic-co-glycolic acid (PLGA)) nanoparticles is in a condensed form, which could protect it against

denaturation and allow to be efficiently taken up by MSCs. In addition, PLGA/PEI nanoparticles possessed the ability to condense DNA for protection against degradation [55]. Blasticidin S manufacturer Table 1 also shows the loading efficiencies of all PEI-modified

gene nanoparticles (groups FNP, GNP, and HNP) which were above 60%. Table 1 Characterization of nanoparticles Group Size (nm) Polydispersion Zeta potential (mV) Loading efficiency (%) Gene Polymer   (n = 3)   (n = 3) (n = 3)     ANP 72.11 ± 3.44 0.164 22.54 ± 3.47 83.4 ± 2.3 TRAIL PEI BNP 71.82 ± 5.18 0.156 21.58 ± 4.16 82.6 ± 1.9 Endostatin PEI CNP 83.02 ± 2.35 0.178 24.65 ± 2.78 78.3 ± 3.8 TRAIL/endostatin PEI DNP 215.06 ± 3.52 0.186 −18.25 ± 2.36 0 None TPGS-b-(PCL-ran-PGA) ENP 236.31 ± 1.44 0.201 23.65 ± 3.65 0 None PEI/TPGS-b-(PCL-ran-PGA) FNP 265.48 ± 4.40 0.229 19.45 Tozasertib nmr ± 1.99 67.4 ± 4.3 TRAIL PEI/TPGS-b-(PCL-ran-PGA) GNP 245.48 ± 6.42 0.215 18.45 ± 2.67 64.6 ± 3.1 Endostatin PEI/TPGS-b-(PCL-ran-PGA) HNP 272.97 ± 4.68 0.245 16.54 ± 1.06 62.5 ± 0.9 TRAIL/endostatin PEI/TPGS-b-(PCL-ran-PGA) Figure 4 Effects of PEI modification, binding of pDNA with TPGS- b -(PCL- ran -PGA)/PEI nanoparticles, and FESEM image of HNP. (A) The effects of PEI modification

on particle size. (B) The effects of PEI modification on surface charge. (C) The binding of pDNA with TPGS-b-(PCL-ran-PGA)/PEI nanoparticles determined by agarose gel electrophoresis. A series of different weight ratios (w/w) of pDNA to TPGS-b-(PCL-ran-PGA)/PEI nanoparticles was loaded on the agarose gel (a, pDNA/NPs = 1:0; b, pDNA/NPs = 1:4; c, pDNA/NPs = 1:10; d, pDNA/NPs = 1:20; e, pDNA/NPs = 1:20; f, pDNA/NPs = 1:20). triclocarban (D) FESEM image of TRAIL- and endostatin-loaded TPGS-b-(PCL-ran-PGA)/PEI nanoparticles (HNP). Surface morphology of the PEI-modified TPGS-b-(PCL-ran-PGA) nanoparticles was observed by FESEM. Figure 4D shows a typical FESEM image of the TPGS-b-(PCL-ran-PGA)/PEI nanoparticles. The morphologies of PEI-modified TPGS-b-(PCL-ran-PGA) particles were sphere-like nanoparticles in shape. The FESEM image further confirmed the particle size detected from DLS. In vitro release The timing of nanoparticle degradation and DNA release appears to have a significant modulating impact on the gene expression [59].

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>